|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.34 SEK | +6.90% |
|
-.--% | +7.43% |
Inhalation Sciences Sweden AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 18.15 million compared to SEK 12.19 million a year ago. Net loss was SEK 4.74 million compared to SEK 12.13 million a year ago.
Basic loss per share from continuing operations was SEK 0.36 compared to SEK 1.07 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.43% | 6M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
INHALATION SCIENCES SWEDEN AB 
